Journal article icon

Journal article

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

Abstract:

OBJECTIVE: To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein (MOG) antibodies, aquaporin-4 (AQP4) antibodies, or seronegativity for both antibodies. METHODS: Sera from patients diagnosed with NMOSD in 1 of 3 centers (2 sites in Brazil and 1 site in Japan) were tested for MOG and AQP4 antibodies using cell-based assays with live transfected cells. RESULTS: Among the 215 patients with NMOSD, 7.4% (16/21...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1212/wnl.0000000000000101

Authors


Callegaro, D More by this author
Lana-Peixoto, MA More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Neuroscience
de Haidar Jorge, FM More by this author
Expand authors...
Publisher:
American Academy of Neurology Publisher's website
Journal:
Neurology Journal website
Volume:
82
Issue:
6
Pages:
474-481
Publication date:
2014-02-05
DOI:
EISSN:
1526-632X
ISSN:
0028-3878
URN:
uuid:170d09f2-df0c-49d8-9455-6291e7bfd627
Source identifiers:
446874
Local pid:
pubs:446874

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP